SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: David Howe who wrote (3286)6/14/1999 11:23:00 AM
From: Bob Swift  Respond to of 10280
 
Big fish starts feeding, 57K just passed at 63 1/2 ask. eom.



To: David Howe who wrote (3286)6/14/1999 11:35:00 AM
From: quidditch  Respond to of 10280
 
SEPR and market valuation.

David, I hope the storm doesn't require FEMA disaster relief .

In addition to the SEPR-specific potholes that have befallen the stock and SEPR longs, prompting a re-evaluation of the appropriate discount rate to assign to a future earnings stream that has its share of time and event risk, it appears that the market as a whole has begun to exact a higher price (with associated lower stock prices) for the risk implicit in putative future earnings streams. This is evident in the cooling of the net fever. Whether it is a function of the c. 75 BP move up in rates since December (in October or so, long bond was at 4.9), or clouds beginning to develop in the goldilocks mentality (stock prices vulnerable, specter of inflation, recoveries overseas) or a more complicated and contested international environment, the market has become less blithe and sanguine about future stories unless their validation is evident here and now. SEPR has validation in the collaborations, but the current costs and the pushing out in time of the earnings stream now weigh more heavily on the market.

Regards. Steven